The only therapeutic approach currently in clinical trials is AAV2-BDNF gene therapy, which requires neurosurgical implantation
What You Need (Injectable Vial Path) For reconstituting an Ion Peptide lyophilized SLU-PP-332 vial: Lyophilized SLU-PP-332 vial (Ion Peptide ships 5 mg and 30 mg sizes) Bacteriostatic water (BAC water sterile water with 0.9% benzyl alcohol) 30 mL syringe with 22-gauge needle for drawing BAC water Insulin syringe (U-100, 0.5 mL or 1 mL with 2931g needle) for individual draws Alcohol swabs for vial-stopper sterilization Sharps container for used needles SLU-PP-332 is more lipophilic than most research peptides
Possible Side Effects BPC-157 is generally well-tolerated in animal and limited human studies
Nowadays, attempts are being made to develop safer dosages and methods and new trends like novel delivery technologies to reduce undesirable effects
2013 (PMID 23055539), which carries a 2021 Expression of Concern
Djakovic Z, Djakovic I, Cesarec V, et al